Tyme, Inc   Report issue

For profit Phase 2
Founded: New York NY United States (2011)

Organization Overview

First Clinical Trial
2016
NCT02796898
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chief Medical Officer TYME Inc. | Tyme, Inc